GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Total Receivables

Awakn Life Sciences (Awakn Life Sciences) Total Receivables : $0.02 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Total Receivables?

Awakn Life Sciences's Total Receivables for the quarter that ended in Jan. 2024 was $0.02 Mil.


Awakn Life Sciences Total Receivables Historical Data

The historical data trend for Awakn Life Sciences's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Total Receivables Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Total Receivables
0.01 0.10 0.11 0.02

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.16 0.24 0.25 0.02

Awakn Life Sciences Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Awakn Life Sciences Total Receivables Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines